上皮中性粒細(xì)胞激活肽78(ENA78)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法)
ELISA Kit DIY Materials for Epithelial Neutrophil Activating Peptide 78 (ENA78)
CXCL5; SCYB5; Chemokine C-X-C-Motif Ligand 5; Small Inducible Cytokine Subfamily B(Cys-X-Cys),Member 5; Neutrophil-activating peptide ENA-78
- 編號KSA860Mu01
 - 物種Mus musculus (Mouse,小鼠)相同的名稱,不同的物種。
 - 試劑內(nèi)容包被抗體、檢測抗體、標(biāo)準(zhǔn)品、HRP標(biāo)記的鏈霉親和素、TMB底物、96孔板
 - 可檢測樣本Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
 - 可適用原理雙抗夾心酶聯(lián)免疫吸附試驗(yàn)法測抗原
 - 可檢測范圍62.5-4000pg/mL
 - 可適靈敏度25.7pg/mL
 - 應(yīng)用自己動手制作ELISA試劑盒的主要材料
 - 下載英文說明書 中文說明書
 - 規(guī)格96T*596T*1096T*2096T*5096T*100
 - 價格¥ 6998¥ 11664¥ 20995¥ 40824¥ 69984
 - 欲了解實(shí)際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
特異性
試劑盒中的抗體對上皮中性粒細(xì)胞激活肽78(ENA78)具有高靈敏度和高特異性,經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。
用法
1.用100μL每孔的工作濃度的包被抗體包被96孔板,4度孵育過夜或者37度孵育2小時;
2.洗板1次;
3.用200μL每孔的工作濃度的封閉液,37度孵育1.5小時;
4.洗板1次。酶標(biāo)板即可用于ELISA實(shí)驗(yàn),后續(xù)使用方法與ELISA同。
儲存
抗體,標(biāo)準(zhǔn)品和HRP標(biāo)記的鏈霉親和素在-20度保存,TMB需在4度保存,96孔板在室溫保存。所有組分保質(zhì)期為1年,試劑一旦開封,在4度保存時間為1個月。
配套試劑
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| APA860Mu02 | 上皮中性粒細(xì)胞激活肽78(ENA78)活性蛋白 | Cell?culture;?Activity?Assays. | 
| RPA860Mu02 | 上皮中性粒細(xì)胞激活肽78(ENA78)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| EPA860Mu61 | 上皮中性粒細(xì)胞激活肽78(ENA78)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| EPA860Mu63 | 上皮中性粒細(xì)胞激活肽78(ENA78)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| APA860Mu61 | 上皮中性粒細(xì)胞激活肽78(ENA78)活性蛋白 | Cell?culture;?Activity?Assays. | 
| RPA860Mu01 | 上皮中性粒細(xì)胞激活肽78(ENA78)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAA860Mu02 | 上皮中性粒細(xì)胞激活肽78(ENA78)多克隆抗體 | WB; IHC; ICC; IP. | 
| PAA860Mu01 | 上皮中性粒細(xì)胞激活肽78(ENA78)多克隆抗體 | WB; IHC; ICC; IP. | 
| LAA860Mu81 | 上皮中性粒細(xì)胞激活肽78(ENA78)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. | 
| LAA860Mu71 | 上皮中性粒細(xì)胞激活肽78(ENA78)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. | 
| SEA860Mu | 上皮中性粒細(xì)胞激活肽78(ENA78)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| AEA860Mu | 抗上皮中性粒細(xì)胞激活肽78抗體(Anti-ENA78)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antibody Detection. | 
| SCA860Mu | 上皮中性粒細(xì)胞激活肽78(ENA78)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. | 
| LMA860Mu | 上皮中性粒細(xì)胞激活肽78(ENA78)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
| KSA860Mu01 | 上皮中性粒細(xì)胞激活肽78(ENA78)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | 自己動手制作ELISA試劑盒的主要材料 | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Journal of Biochemical and Molecular Toxicology | Ameliorative Effects of Curcumin on Fibrinogen-Like Protein-2 Gene Expression, Some Oxido-Inflammatory and Apoptotic Markers in a Rat Model of l-Arginine-Induced Acute Pancreatitis.[Pubmed:26862043] | 
| Journal of Biochemical and Molecular Toxicology | Ameliorative Effects of Curcumin on Fibrinogen-Like Protein-2 Gene Expression, Some Oxido-Inflammatory and Apoptotic Markers in a Rat Model of l-Arginine-Induced Acute Pancreatitis[pubmed:26862043] | 
| OncoTargets and Therapy | The clinical significance of CXCL5 in non-small cell lung cancer.[pubmed:29200871] | 
| Biochimie | Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway[Pubmed:29471001] | 
| Cancer?Biology?&?Therapy | Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38?…[Pubmed: 30404567] | 
| Respiratory?Research | Phospholipase Cε plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from?…[Pubmed: 30634975] | 
| American Journal of Pathology | Interleukin17–CXCR2 axis facilitates breast cancer progression by up-regulating neutrophil recruitment[Pubmed: 31654638] | 
| Bioactive Materials | Secretions from hypochlorous acid-treated tumor cells delivered in a melittin hydrogel potentiate cancer immunotherapy[34820587] | 
| Am J Cancer Res | Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma[Pubmed:35141005] | 


